Mass treatment of parasitic disease: Implications for the development and spread of anthelmintic resistance

Antimicrobial Resistance

Volumn 6, Issue , 2010, Pages 120-137

  Churcher, Thomas S ^a   Kaplan, Ray M ^c   Ardelli, Bernadette F ^e   Schwenkenbecher, Jan M ^b   Basáñez, María Gloria ^a   Lammie, Patrick J ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF GEORGIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e BRANDON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861216301     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000298760     Document Type: Chapter

References (43)

1. Prichard RK, Hall CA, Kelly JD, Martin IC, Donald AD: The problem of anthelmintic resistance in nema todes. Aust Vet J 1980;56:239-251.
2. Anderson TJC, Blouin MS, Beech RN: Population biology of parasitic nematodes: applications of genetic markers. Adv Parasitol 1998;41:219-283.
3. Roos MH, Kwa MSG, Grant WN: New genetic and practical implications of selection for anthelmintic resistance in parasitic nematodes. Parasitol Today 1995;11:148-150.
4. Blouin MS: Mitochondrial DNA diversity in nematodes. J Helminthol 1998;72:285-289.
5. Blouin MS, Yowell CA, Courtney CH, Dame JB:Host movement and the genetic structure of populations of parasitic nematodes. Genetics 1995;141:1007-1014.
6. Kotze AC, Coleman GT, Mai A, McCarthy JS: Field evaluation of anthelmintic drug sensitivity using in vitro egg hatch and larval motility assays with Necator americanus recovered from human clinical isolates. Int J Parasitol 2005;35:445-453.
7. Jackson F, Coop R: The development of anthelmintic resistance in sheep nematodes. Parasitology 2000; 120:S95-S107.
8. Conway DP: Variance in effectiveness of thiabendazole against Haemonchus contortus in sheep. Am J Vet Res 1964;25:844-845.
9. Kaplan RM: Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol 2004;20:477-481.
10. World Health Organization: Weekly Epidemiological Review, 2 June, No. 22. Geneva, WHO, 2006, pp 221-232.
11. Gomez-Priego A, Mendoza R, de-la-Rosa JL:Prevalence of antibodies to Onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin. Clin Diagn Lab Immun 2005;12:40-43.
12. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJ, van Oortmarssen G, Boatin BA, Habbema JD: Can ivermectin mass treatments eliminate onchocerciasis in Africa? B World Health Organ 2002;80:384-391.
13. Oqueka T, Supali T, Ismid IS, Purnomo, Ruckert P, Bradley M, Fischer P: Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia. Filaria J 2005;4:5.
14. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD: Incorporating a rapidimpact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 2006;3:e102.
15. Cully DF, Vassilatis DK, Liu KK, Paress PS, Vanderploeg LHT, Schaeffer JM, Arena JP: Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 1994; 371:707-711.
16. Harnett W, Kusel JR: Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro. Parasitology 1986;93:401-405.
17. Lacey E: The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drugresistance to benzimidazoles. Int J Parasitol 1988;18:885-936.
18. Maizels RM, Denham DA: Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 1992;105:S49-S60
19. Martin RJ, Bai GX, Clark CL, Robertson AP:Methyridine (2-[2-methoxyethyl]-pyridine) and levamisole activate different ACh receptor subtypes in nematode parasites: a new lead for levamisoleresistance. Brit J Pharmacol 2003;140:1068-1076.
20. Njue AI, Prichard RK: Genetic variability of glutamate-gated chloride channel genes in ivermectinsusceptible and-resistant strains of Cooperia oncophora. Parasitology 2004;129:741-751.
21. Prichard RK: Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol 2001;17:445-453.
22. Schwab AE, Boakye DA, Kyelem D, Prichard RK:Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am J Trop Med Hyg 2005;73:234-238.
23. Drogemuller M, Failing K, Schnieder T, von Samson-Himmelstjerna G: Effect of repeated benzimidazole treatments with increasing dosages on the phenotype of resistance and the beta-tubulin codon 200 genotype distribution in a benzimidazole-resistant cyathostomin population. Vet Parasitol 2004;123:201-213.
24. Robinson MW, McFerran N, Trudgett A, Hoey L, Fairweather I: A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement. J Mol Graph Model 2004; 23:275-284.
25. Eberhard ML, Lammie PJ, Dickinson CM, Roberts JM: Evidence of nonsusceptibility to diethylcarbamazine in Wuchereria bancrofti. J Infect Dis 1991; 163:1157-1160.
26. Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Lazdins-Helds JK, Ahmed K, Boatin BA, Boakye DA, Edwards G: Thirty-month follow-up of suboptimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasit 2004;98:359-370.
27. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK: Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet. 2007;369:2021-2029.
28. Ardelli BF, Guerriero SB, Prichard RK: Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity. Parasitology 2006;132:375-386.
29. Eng JKL, Prichard RK: A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated-and ivermectin-treated patients. Mol Biochem Parasit 2005;142:193-202.
30. Churcher TS; Schwab AE; Prichard RK; Basáñez MG: An Analysis of genetic diversity and inbreeding in Wuchereria bancrofti: implications for the spread and detection of drug resistance. PLoS NTD 2008;2:e211
31. Van Wyk JA: Refugia: overlooked as perhaps the most potent factor concerning the development of anthelmintic resistance. Onderstepoort J Vet Res 2001;68:55-67.
32. Sangster NC, Dobson RJ: Anthelmintic resistance; in: Lee DL (ed): The Biology of Nematodes. London, Taylor & Francis, 2002, pp 531-567.
33. Subramanian S, Stolk WA, Ramaiah KD, Plaisier AP, Krishnamoorthy K, Van Oortmarssen GJ, Dominic Amalraj D, Habbema JD, Das PK: The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology 2004;128:467-482.
34. Filipe JA, Boussinesq M, Renz A, Collins RC, Vivas-Martinez S, Grillet ME, Little MP, Basáñez MG:Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci USA 2005; 102:15265-15270.
35. Barnes EH, Dobson RJ, Barger IA: Worm control and anthelmintic resistance: adventures with a model. Parasitol Today 1995;11:56-63.
36. Smith G, Grenfell BT, Isham V, Cornell S:Anthelmintic resistance revisited: under-dosing, chemoprophylactic strategies, and mating probabilities. Int J Parasitol 1999;29:77-91.
37. Churcher TS; Basáñez MG: Density dependence and the spread of anthelmintic resistance. Evolution 2008;62:528-537.
38. De Clercq D, Sacko M, Behnke J, Gilbert F, Dorny P, Vercruysse J: Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg 1997;57:25-30.
39. Reynoldson JA, Behnke JM, Pallant LJ, Macnish MG, Gilbert F, Giles S, Spargo RJ, Thompson RC:Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Trop 1997;68:301-312.
40. Albonico M, Wright V, Ramsan M, Haji HJ, Taylor M, Savioli L, Bickle Q: Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms. Int J Parasitol 2005;35:803-811.
41. Albonico M, Wright V, Bickle Q: Molecular analysis of the beta-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Mol Biochem Parasit 2004;134:281-284.
42. Botros S, Sayed H, Amer N, El-Ghannam M, Bennett JL, Day TA: Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int J Parasitol 2005;35:787-791.
43. Geary TG, Conder GA, Bishop B: The changing landscape of antiparasitic drug discovery for veterinary medicine. Trends Parasitol 2004;20:449-455.